Trials / Completed
CompletedNCT03232255
Clinical Benefit of a Mouthrinse for the Treatment of Dentine Hypersensitivity
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- InQpharm Group · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This study is to evaluate the benefit and tolerability of a Mouthrinse (IQP-OLP-101) in the treatment of dentine hypersensitivity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Mouthrinse (IQP-OLP-101) | Rinse/gargle 10mL of Mouthrinse for 60 seconds after tooth brushing, twice a day. |
Timeline
- Start date
- 2017-08-25
- Primary completion
- 2017-12-07
- Completion
- 2017-12-07
- First posted
- 2017-07-27
- Last updated
- 2018-01-03
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03232255. Inclusion in this directory is not an endorsement.